Fluclotizolam is a thienotriazolodiazepine derivative which was first synthesised in 1979, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified in 2017. This product is intended for laboratory rese

Nitromethaqualone is an kind of methaqualone that has similar sedative and hypnotic properties. It is significantly more potent (10x) compared to the parent compound; the typical dose is approximately 25 mg. However, the aromatic nitro group is metabolise

Flubromazepam is a benzodiazepine derivative which was first synthesized in 1960, but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the grey market as a novel designer drug. It is a structural

Deschloroetizolam (also known as Etizolam-2) is a thienotriazolodiazepine that is the dechlorinated of the closely related to etizolam. The compound has been sold as a designer drug… This product is intended for laboratory research purposes only and are

Pyrazolam (SH-I-04)is a benzodiazepine derivative originally developed by a team led by Leo Sternbach at Hoffman-La Roche in the 1970s, and subsequently "rediscovered" and sold as a designer drug starting in 2012. Pyrazolam has structural similarities t

SL-164 is methaqualone developed in the late 1960s by a team at Sumitomo. SL-164 has similar sedative, hypnotic and anticonvulsant properties to the parent compound, but was never marketed for clinical use. This product is intended for laboratory resear

Flunitrazolam is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties, Super potent, very hypnotic, king of benzos. it was never FDA approved and was never available to the public. This product is

3-HYDROXYPHENAZEPAM is a benzodiazepine with hypnotic, sedative, anxiolytic, and anticonvulsant properties, Relative to phenazepam, 3-hydroxyphenazepam has diminished myorelaxant properties, but is about equivalent in most other regards.Like other benzodi